These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 3316711)
1. Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus. Zhao BT; Prince G; Horswood R; Eckels K; Summers P; Chanock R; Lai CJ J Virol; 1987 Dec; 61(12):4019-22. PubMed ID: 3316711 [TBL] [Abstract][Full Text] [Related]
2. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. Falgout B; Bray M; Schlesinger JJ; Lai CJ J Virol; 1990 Sep; 64(9):4356-63. PubMed ID: 2143542 [TBL] [Abstract][Full Text] [Related]
3. Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis. Bray M; Zhao BT; Markoff L; Eckels KH; Chanock RM; Lai CJ J Virol; 1989 Jun; 63(6):2853-6. PubMed ID: 2724416 [TBL] [Abstract][Full Text] [Related]
4. Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. Falgout B; Chanock R; Lai CJ J Virol; 1989 May; 63(5):1852-60. PubMed ID: 2522997 [TBL] [Abstract][Full Text] [Related]
6. Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. Zhang YM; Hayes EP; McCarty TC; Dubois DR; Summers PL; Eckels KH; Chanock RM; Lai CJ J Virol; 1988 Aug; 62(8):3027-31. PubMed ID: 2969058 [TBL] [Abstract][Full Text] [Related]
7. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Mason PW; Pincus S; Fournier MJ; Mason TL; Shope RE; Paoletti E Virology; 1991 Jan; 180(1):294-305. PubMed ID: 1845826 [TBL] [Abstract][Full Text] [Related]
8. Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue. Deubel V; Kinney RM; Esposito JJ; Cropp CB; Vorndam AV; Monath TP; Trent DW J Gen Virol; 1988 Aug; 69 ( Pt 8)():1921-9. PubMed ID: 3404119 [TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity and protective effects in mice of a recombinant dengue 2 Tonga virus NS1 protein produced in a baculovirus expression system. Qu X; Chen W; Maguire T; Austin F J Gen Virol; 1993 Jan; 74 ( Pt 1)():89-97. PubMed ID: 8423452 [TBL] [Abstract][Full Text] [Related]
10. Expression of the NS1 gene of dengue virus type 2 using vaccinia virus. Dimerisation of the NS1 glycoprotein. Parrish CR; Woo WS; Wright PJ Arch Virol; 1991; 117(3-4):279-86. PubMed ID: 1826827 [TBL] [Abstract][Full Text] [Related]
11. Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection. Eckels KH; Dubois DR; Summers PL; Schlesinger JJ; Shelly M; Cohen S; Zhang YM; Lai CJ; Kurane I; Rothman A Am J Trop Med Hyg; 1994 Apr; 50(4):472-8. PubMed ID: 8166355 [TBL] [Abstract][Full Text] [Related]
12. Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes. Rothman AL; Kurane I; Lai CJ; Bray M; Falgout B; Men R; Ennis FA J Virol; 1993 Feb; 67(2):801-6. PubMed ID: 7678307 [TBL] [Abstract][Full Text] [Related]
13. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis. Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392 [TBL] [Abstract][Full Text] [Related]
14. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection. Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251 [TBL] [Abstract][Full Text] [Related]
15. Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia viruses. Hahn YS; Lenches EM; Galler R; Rice CM; Dalrymple J; Strauss JH Arch Virol; 1990; 115(3-4):251-65. PubMed ID: 2260923 [TBL] [Abstract][Full Text] [Related]
16. Live recombinant vaccines using genetically engineered vaccinia virus. Paoletti E; Perkus ME; Piccini A Antiviral Res; 1985; Suppl 1():301-7. PubMed ID: 3866514 [No Abstract] [Full Text] [Related]
17. Cleavage of dengue virus NS1-NS2A requires an octapeptide sequence at the C terminus of NS1. Hori H; Lai CJ J Virol; 1990 Sep; 64(9):4573-7. PubMed ID: 2143546 [TBL] [Abstract][Full Text] [Related]
18. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. Stott EJ; Taylor G; Ball LA; Anderson K; Young KK; King AM; Wertz GW J Virol; 1987 Dec; 61(12):3855-61. PubMed ID: 3316707 [TBL] [Abstract][Full Text] [Related]
19. Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus. Lin YL; Borenstein LA; Selvakumar R; Ahmed R; Wettstein FO Virology; 1992 Apr; 187(2):612-9. PubMed ID: 1312271 [TBL] [Abstract][Full Text] [Related]
20. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. Pincus S; Mason PW; Konishi E; Fonseca BA; Shope RE; Rice CM; Paoletti E Virology; 1992 Mar; 187(1):290-7. PubMed ID: 1736531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]